Friday, March 30, 2007

UPDATE 1-KV to buy rights to Vivus' menopause spray

(Reuters) - St. Louis-based KV said the deal could have a break-even or slightly dilutive effect on its fiscal 2008 results of operations, but is expected to add to earnings thereafter.

KV said it expects the product to be approved and launched during the second half of its fiscal 2008.


Read more at Reuters.com Government Filings News

No comments: